Tags: Coronavirus | Coronavirus Special | Health Topics | Vaccines | Cold/Flu | glaxosmithkline | gsk

GSK to Produce 1B Doses of Adjuvant Vaccine Booster in '21

a microscope sits before a world coronavirus impact map with a vile marked vaccine
(Dmitri Maruta/Dreamstime)

Saturday, 30 May 2020 09:16 AM

British drugmaker GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the company said Thursday.

The company added it was in talks with governments on backing for the program, which would effectively allow the expansion of the scale of production of future successful vaccines for the disease caused by the novel coronavirus.

Moderna Inc said Friday it had started dosing patients in a mid-stage study with its experimental coronavirus vaccine and eventually plans to enroll 600 patients for the trial.

There are currently no approved treatments or vaccines to treat COVID-19, and experts predict a safe and effective vaccine could take 12-18 months from the start of development.

© 2020 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
SciTech
British drugmaker GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the company said Thursday.
glaxosmithkline, gsk, boosters, covid-19, pandemic, doses
123
2020-16-30
Saturday, 30 May 2020 09:16 AM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved